Medicare Enrolled
Dr. Ratesh Khillan, M.D.
General Acute Care Hospital · Brooklyn, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Khillan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khillan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khillan
Dr. Ratesh Khillan is a general acute care hospital specialist in Brooklyn, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Khillan performed 909 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Khillan received a total of $28,450 from 71 pharmaceutical and/or device companies across 989 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khillan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 21% volume in NY
$28,450 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗909
Medicare services
Top 21% in NY for general acute care hospital
Not available
Unique patients (not deduplicated)
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
365 | $111 | $175 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
141 | $61 | $150 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
125 | $52 | $110 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
109 | $13 | $75 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
73 | $82 | $128 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
70 | $74 | $150 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
26 | $150 | $275 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
15.5% high complexity
12.0% medium
72.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$28,450
Total received (2018-2024)
Avg $4,064/year across 7 years
Top 5% in NY for general acute care hospital
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
71
Companies
989
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$8,109
2023
$3,114
2022
$5,411
2021
$3,633
2020
$2,032
2019
$3,196
2018
$2,954
Payments by company (2024)
E.R. Squibb & Sons, L.L.C.
$3,365
PFIZER INC.
$1,432
Novartis Pharmaceuticals Corporation
$937
Celgene Corporation
$393
Takeda Pharmaceuticals U.S.A., Inc.
$195
Regeneron Healthcare Solutions, Inc.
$193
Merck Sharp & Dohme LLC
$189
Janssen Biotech, Inc.
$161
Rigel Pharmaceuticals, Inc.
$117
Astellas Pharma US Inc
$113
Incyte Corporation
$110
TAIHO ONCOLOGY, INC.
$100
AstraZeneca Pharmaceuticals LP
$99
SOBI, INC
$81
Aveo Pharmaceuticals, Inc.
$80
GENZYME CORPORATION
$65
Agios Pharmaceuticals, Inc.
$64
Daiichi Sankyo Inc.
$59
PUMA BIOTECHNOLOGY, INC.
$56
Bayer Healthcare Pharmaceuticals Inc.
$55
Mirati Therapeutics, Inc.
$48
Eisai Inc.
$46
Gilead Sciences, Inc.
$45
Stemline Therapeutics Inc.
$31
ARRAY BIOPHARMA INC
$31
JAZZ PHARMACEUTICALS INC.
$24
Coherus Biosciences Inc.
$19
Top 3 companies account for 70.7% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$4,805
PFIZER INC.
$2,600
Janssen Biotech, Inc.
$1,980
Novartis Pharmaceuticals Corporation
$1,948
Astellas Pharma US Inc
$1,671
Incyte Corporation
$1,298
Celgene Corporation
$943
Amgen Inc.
$913
Merck Sharp & Dohme Corporation
$877
GENZYME CORPORATION
$726
Alexion Pharmaceuticals, Inc.
$692
Takeda Pharmaceuticals U.S.A., Inc.
$692
Lilly USA, LLC
$650
Merck Sharp & Dohme LLC
$643
Rigel Pharmaceuticals, Inc.
$627
Regeneron Healthcare Solutions, Inc.
$486
Taiho Oncology, Inc.
$479
AstraZeneca Pharmaceuticals LP
$437
Eisai Inc.
$413
Global Blood Therapeutics, Inc.
$391
Daiichi Sankyo Inc.
$367
Dova Pharmaceuticals
$331
Bayer HealthCare Pharmaceuticals Inc.
$304
ARRAY BIOPHARMA INC
$294
Seagen Inc.
$282
TAIHO ONCOLOGY, INC.
$242
Ipsen Biopharmaceuticals, Inc
$242
Genentech USA, Inc.
$217
SOBI, INC
$203
EISAI INC.
$201
BeiGene USA, Inc.
$196
Gilead Sciences, Inc.
$195
Pharmacyclics LLC, An AbbVie Company
$156
Exelixis Inc.
$123
Foundation Medicine, Inc.
$122
EMD Serono, Inc.
$119
Mirati Therapeutics, Inc.
$114
Kyowa Kirin, Inc.
$87
Puma Biotechnology, Inc.
$83
Verastem, Inc.
$81
Aveo Pharmaceuticals, Inc.
$80
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$79
Stemline Therapeutics Inc.
$79
GlaxoSmithKline, LLC.
$76
Agios Pharmaceuticals, Inc.
$64
Myovant Sciences Inc.
$61
Sobi, Inc
$59
PUMA BIOTECHNOLOGY, INC.
$56
Bayer Healthcare Pharmaceuticals Inc.
$55
Lexicon Pharmaceuticals, Inc.
$55
SANOFI-AVENTIS U.S. LLC
$50
Kite Pharma, Inc.
$49
Seattle Genetics, Inc.
$47
Pharmacyclics LLC, an AbbVie Company
$44
INSYS Therapeutics Inc
$38
Clovis Oncology, Inc.
$38
Apellis Pharmaceuticals, Inc.
$27
Emmaus Medical, Inc.
$26
JAZZ PHARMACEUTICALS INC.
$24
Janssen Pharmaceuticals, Inc
$23
TESARO, Inc.
$22
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
Jazz Pharmaceuticals Inc.
$20
Spectrum Pharmaceuticals Inc.
$20
Coherus Biosciences Inc.
$19
Secura Bio, Inc.
$17
TerSera Therapeutics LLC
$16
Teva Pharmaceuticals USA, Inc.
$15
Shire North American Group Inc
$14
TOLMAR Pharmaceuticals, Inc.
$14
Alnylam Pharmaceuticals Inc.
$13
Top 3 companies account for 33.0% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALUNBRIG · Alecensa · Aranesp · Avastin · BENDEKA · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Beleodaq · CABOMETYX · CAMZYOS · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · ENHERTU · ERLEADA · Empaveli · Endari · Enhertu · Erleada · FARESTON · FARYDAK · FASLODEX · FOTIVDA · FOUNDATIONONE · Fabhalta · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · Inrebic · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · LifeVest · Lonsurf · MEKINIST · MONJUVI · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Orserdu · PEMAZYRE · PIQRAY · PROMACTA · PYRUKYND · Perjeta · Pomalyst · Poteligeo · REBLOZYL · RETEVMO · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · Rubraca · SANCUSO · SARCLISA · SCEMBLIX · SOLIRIS · SUTENT · SYNDROS · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TUKYSA · Tavalisse · Tazverik · Trodelvy · Turalio · ULTOMIRIS · Udenyca · Ultomiris · VELCADE · VERZENIO · VOTRIENT · XALKORI · XARELTO · XGEVA · XOSPATA · XTANDI · Xermelo · Xofigo · Xtandi · Yescarta · ZEJULA · ZEPZELCA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
General acute care hospitals in nearby ZIP areas
332
County median income
$78,548
Nearest hospital to ZIP centroid (approximate)
KINGS COUNTY HOSPITAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Khillan is a clinical cardiology specialist, with above-average Medicare volume (top 21% in NY), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Khillan experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Khillan performed 365 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Khillan receive payments from pharmaceutical companies?
Yes. Dr. Khillan received a total of $28,450 from 71 companies across 989 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khillan's costs compare to other general acute care hospitals in Brooklyn?
Dr. Khillan's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khillan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
General Acute Care Hospitals in Brooklyn
Browse general acute care hospitals in Brooklyn ranked by procedure volume and transparency data.
Highest volume
Top General Acute Care Hospitals in NY
General acute care hospitals ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to General Acute Care Hospitals in NY
Which NY general acute care hospitals receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology